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Thousands of DNA lesions, in form of chemicalmodifications, base loss and singlestrand
breaksareestimatedtooccurineverycellperday.Excisionrepairpathwaysandcellcycle
checkpoints have evolved as part of the cellular response to DNA damage. Base excision
repair (BER) can remove subtle DNA lesions, while nucleotide excision repair (NER) can
removemorebulkyhelixdistortingDNAdamage.

In paper I, we characterized two Cockayne syndrome (CS) patients deficient in a sub
pathway of NER, transcription coupled (TC) NER. We hypothesized that the underlying




of this thesis, an update on CS proteins, their known human mutations and clinical
characteristics is further reviewed. Still, a molecular explanation of the CS pathology is




RNA primers in lagging strand DNA replication. Thus, it could be hypothesized that FEN1






(YFP) tag fusedtoFEN1, inordertostudyFEN1YFPkinetics inBERandDNAreplication in
vivo.Forthefirsttime,thekineticsoftheFEN1YFPprotein inLPBER,expressedfromthe
Fen1YFPgeneatanendogenouslevel,couldbeinvestigatedinlivingcells,followinghighly
localized laser irradiation. This microirradiation method produces a high concentration
(localdamage)andwidespectrumofDNAlesions,includingLPBERsubstratesforFEN1.We





recruitment to DNA repair intermediates in LPBER. Fluorescence recovery after













maintain cellular function throughout the lifespan of a cell and an organism. Then again,
cells receive tens of thousands of DNA lesions per day (Lindahl and Barnes, 2000). Time
dependentaccumulationofdamageincellsandorgansisassociatedwithgradualfunctional
decline and aging (Kirkwood, 2005). Such lesions can block genome replication and
transcription,andiftheyarenotrepairedorarerepairedincorrectly,theyleadtomutations
orwiderscalegenomeaberrationsthatthreatenthecellororganismsviability.Hydrolysisof
DNA is the most common damage, with depurination being themost prevalent of these




Cellular metabolism generates reactive oxygen species (ROS), reactive nitrogen species
(RNS), lipidperoxidationproducts,endogenousalkylatingagents,estrogenandcholesterol
metabolites, and reactive carbonyl species, all ofwhichdamageDNA (DeandVan, 2004).
ROS arising as byproducts from oxidative respiration, redoxcycling events involving
environmentaltoxicagents,Fentonreactionsmediatedbyheavymetals,andROSandRNS





















radioactive compounds.Uraniumdecay, forexample,produces radioactive radongas that
accumulates in somehomes and contributes to lungcancer incidence. Environmental and
industrial chemicals create a huge diversity of DNA adducts and crosslinking of DNA. The
most prevalent environmental cancercausing chemicals today are those produced by
tobaccoproducts,whichcausevariouscancers,mostnotablythoseofthe lung,oralcavity





DNA, and where mutations are induced, can go into senescence, programmed cell
death/apoptosis or unregulated cell division, the latter which can lead to cancer. The
outcomeofthecelldependsofthetypeofdamage.Somelesionsareprimarilymutagenic,
whileothers aremainly cytotoxicor cytostatic. Both typesof outcomes indifferent ratios
can result frommanyDNA lesions, dependingon the locationandnumberof lesions, cell
type,andstage inthecellcycleanddifferentiation (AkbariandKrokan,2008;Hoeijmakers,
2009).Theoxidative lesion7,8dihydro8oxoguanine isamutagenic lesion,pairingequally
wellwithcytosine(normalpairing)andguanine(abnormalpairing)duringDNAreplication,
causingGCTAtransversions(AkbariandKrokan,2008).DSBsinducedbyionizingradiation
or that occur during the processing of interstrand crosslinks are primarily cytotoxic or





A complex genomemaintenance apparatus controls DNA damage. It consists of multiple




checkpoint, signal transduction, and effector systems connected with replication,
transcription,recombination,chromatinremodelinganddifferentiation(HarperandElledge,





class of repair proteins that can be used only once. For instance O6methylguanine
methyltransferase(MGMTorAGT)repairsasingleO6methylguaninelesionbytransferring
themethyl fromaguanine inDNA to a cysteine in theenzyme, thereby inactivating itself
(XuWelliver and Pegg, 2002). All organisms from bacteria to man have evolved distinct
repair systems to combat the threats posed by DNA damage (Taylor and Lehmann,
1998;Hoeijmakers,2001;Welleretal.,2002).

Figure 1 DNA damage, repair mechanisms and consequences. a, Common DNA damaging agents
(top); examples of DNA lesions induced by these agents (middle); and most relevant DNA repair
mechanismresponsiblefortheremovalofthelesions(bottom).b,AcuteeffectsofDNAdamageon
cellcycleprogression, leading to transientarrest in theG1,S,G2andMphases (top),andonDNA
metabolism(middle).LongtermconsequencesofDNAinjury(bottom)includepermanentchangesin
the DNA sequence (pointmutations affecting single genes or chromosome aberrationswhichmay
involve multiple genes) and their biological effects. Abbreviations: cisPt and MMC, cisplatin and
mitomycinC, respectively (bothDNAcrosslinking agents); (6–4)PP andCPD, 6–4photoproduct and






In addition to direct lesion reversal, different multistep DNA repair systems exist: base
excisionrepair(BER),nucleotideexcisionrepair(NER),mismatchrepair(MMR),homologous









agents and develop liver and lung tumors (Iwakumaet al., 1997).Mice lacking functional
Alkbh2 andAlkbh3 genes are viable with no overt phenotype. However,Alkbh2 deficient
mice accumulate significant levels of 1meA in the genome, and embryonic fibroblast cells




Themismatch repairpathway removesmispairednucleotidesand insertion/deletion loops
that result from slippage of the DNA polymerase during replication ((Jiricny, 2006) and
Figure1).IdentificationofmutationsinhumanMMRgenesinpatientswithhereditarynon
polyposis colorectal cancer (HNPCC) revealed the importance of the MMR pathway in
humanetiology(Papadopoulosetal.,1994;Vasen,2007).

The removal of helixdistorting lesions that interfere with base pairing and obstruct
replicationandtranscriptionaredealtwithbytheNERpathway((Cleaveretal.,2009)and
Figures1and2). Transcriptioncoupled repair (TCR),oneof the two subpathwaysofNER
(Figures 2 and 3), targets only lesions that hinder transcription, through arresting RNA
polymeraseII(FousteriandMullenders,2008).Globalgenome(GG)NERsurveysdamageto
DNA that occurs anywhere in the genome (Figures 2 and 3). Individuals with inherited
defects inNER are characterizedwith hypersensitivity to the sun. This is due to defective
handling of UV damage, however, other NER associated clinical features are extremely
heterogenous(Cleaveretal.,2009).Xerodermapigmentosum(XP),Cockaynesyndrome(CS)
and trichothiodystrophy (TTD) are three rare syndromes arising frommutations in genes
Introduction
13 
coding forNER proteins (Bootsmaet al., 1995;Kraemer et al., 2007). XP patients have an
extremely high riskof developing skin cancer at youngage. This is a featurenot found in







small chemical alterations of DNA bases ((Baute and Depicker, 2008;Zharkov, 2008) and
Figures1and2).MicelackingindividualBERproteinseithershownoparticularphenotype,
or a severe, mostly embryonic lethal phenotype. This can be explained by backup





et al., 2003;Dallosso et al., 2008). Biallelic germlinemutations in theMUTYH gene cause
increasedGCtoTAtransversionsintheAPCgene,whichcontrolstheproliferationofcolon
cells (Fearnheadetal., 2001).UracilDNANglycosylasehasbeen shown tobe involved in
immunoglobulin (Ig) classswitch recombination (CSR) and somatic hypermutation (SHM)
generation(Radaetal.,2002).RecessivemutationsofthegeneencodingUNGarelinkedto
defects inCSRandtheSHMpattern inpatientswithhyperIgGMsyndrome.UNGdeficient
mice were shown to have a highly elevated risk, 22 fold, of developing Bcell lymphoma
(Andersenetal.,2005).Inmice,thesingleknockoutsofOgg1andMutYappearnormalwith
no obvious cancer phenotype. However, the double knockoutOgg1/Mutyh develop lung
tumors(Xieetal.,2004).PolymorphismsinBERgenesareassociatedwithincreasedriskfor
certaincancers(Xuetal.,2008),however,conflictingreportsnecessitatefunctionalstudies
of these polymorphisms. Accumulating evidence also suggests that BER might play a
fundamental role in the development of agerelated neurodegenerative diseases, such as
Alzheimer’sdisease (AD),Parkinson’sdisease (PD),amyotrophic lateral sclerosis (ALS),and








Survival andMutagenesis. Doublestrand breaks (DSBs) in DNA are highly cytotoxic and cytostatic
formsofdamage.Theyarerepairedthroughnonhomologousendjoining(NHEJ),whichsimply joins
the ends of DNA strands and is associated with an elevated risk of mutagenesis, or through
homologousrecombination(HR),whichtakesplaceafterreplicationandusestheintactcopyonthe





the presence of highly cytotoxic DSBs and may thereby enhance mutagenesis. HR also promotes
cellular survival, but without inducingmutations. Baseexcision repair (BER) is involved with small
DNAadducts(mainlyoxidativeandalkylatinglesions),someofwhichmaybehighlymutagenic(e.g.,
7,8dihydro8oxoguanine), and some cytotoxic. When these lesions block elongating RNA
polymerase,transcriptioncoupledrepair(TCR)removesthedamage,allowingthevitaltranscription
to resume. BER prevents mutagenesis and promotes cellular survival. Transcriptioncoupled
nucleotideexcision repair (TCNER) is specific to transcriptionblocking bulky adducts, which are
eliminatedthroughouttheentiregenomebytheglobalgenomenucleotideexcisionrepair(GGNER)
system. DNA damage that blocks the regular replicationmachinery involving DNA polymerase /
(e.g.,breaksandcrosslinks)canberepaired,bypassedbyhomologousrecombination,whichinvolves
template switching and strand displacement, or bypassed by translesional synthesis (TLS), a
specialized, relatively errorfree (but still somewhat mutagenic) means of bypassing a specific











of DNA. NHEJ is also acting upon V(D)J and classswitch recombination intermediates
(Rooneyetal.,2004;ChaudhuriandAlt,2004).InactivationofessentialcomponentsofNHEJ
in mice results in a severe combined immunodeficiency (SCID) phenotype (Bosma et al.,
1983;Bluntetal.,1995;Kirchgessneretal.,1995). IntheSorG2phaseofthecellcycle,HR
uses the identical sister chromatid to align the broken ends and accurately insertmissing
informationthroughasetofpathways(KroghandSymington,2004).ThissecondDSBrepair
mechanismisalsodealingwithstalledandcollapsedreplicationforks(AguileraandGomez
Gonzalez, 2008).Defects inHR cause thehuman syndromesAT (ataxia telangiectasia)like
disorder(ATLD)andNijmegenBreakageSyndrome(NBS),andpredispositionhasbeenlinked
tomutationsintheMRN(MRE11/RAD50/NBS1)complex(ThompsonandSchild,2002).ATLD
is characterized by progressive neurodegeneration, whereas NBS is characterized by
microcephaly, growth retardation, immunodeficiency andpredisposition to tumors (Taylor
et al., 2004;Czornak et al., 2008). The RecQ helicases are required for efficient HR, and
mutations in the RecQ helicase genes are associated with Werner Syndrome (WS),
RothmundThomson syndrome (RTS) and Blooms syndrome (BS) (Hickson, 2003).WS and
RTSarecharacterizedwithaprematureaging,BSpatientshavea strongpredisposition to
cancer(Bohr,2008).Defects inDSBrepairgenescauseembryonic lethality,developmental









cytotoxic drugs used in chemotherapy (Nouspikel, 2009). Two major UV photolesions
repairedbyNERarecyclobutanepyrimidinedimer(CPD)andthepyrimidinepyrimidone(6
4) photoproduct (64PP). Benzo(a)pyrene DNA adducts induced by cigarette smoke and
lesionsformedbychemicalcarcinogens, likecisplatin,arealsorecognizedandremovedby
NER(Wood,1996;Sancar,1996;Friedbergetal.,2006).Aftersensingthelesion,thedamaged




many different lesions can be handled by a common set of enzymes, a sequential action
involvingover30proteins.Dependingonwhetherthedamageoccursinatranscriptionally
inactive or active domain, repair can occur by two subpathways: global genomic repair
(GGR) or transcriptioncoupled repair (TCR) (Friedberg, 1996).GGRand TCR differ in their
mode of damage recognition; however, all subsequent steps are common to these two
repair pathways (Figure 3). TCR ensures that the transcribed strand of active genes is
repaired with higher priority than the rest of the genome, probably by using RNA
polymerase II (RNAPII)asa lesionsensor (Mellonetal.,1986). InGGR inhumancells, the
heterodimer XPC/HR23B (XPC in figure 3) appears to be the major damage recognition
factor, detecting the helix distortion and stabilizing the DNA bend. XPC/HR23B recruits
transcriptionfactorTFIIH,atensubunitcomplex(includingXPB,XPDandTTDA),atthesite








Hereditary defects inNER are associatedwith several human autosomal recessive genetic
disorders, such as xeroderma pigmentosum (XP), Cockayne syndrome (CS) and
trichothiodystrophy (TTD) (Lehmann, 2001;Bootsma et al., 2001). These three syndromes
are all characterized by UV sensitivity, however, they display complex and varying
pathologiesthatinvolvemostsystemicandneuraltissuesandorgans(Cleaveretal.,2009).
XPpatientssufferfromahighincidenceofskincancer,morethan1,000timesashighasthe
incidence in thegeneralpopulation (BenhamouandSarasin,2000).Mutations in13genes
(XPAG,whereDDB1andDDB2encodetwosubunitsoftheXPEcomplex,ERCC1,XPV,CSA,
CSB,TTDA) associatedwithNER cause awide rangeof clinical symptoms, frommild solar
sensitivitytosevereskincancers,developmentaldisordersandneurodegeneration(Kraemer












in the genome (e.g., photoproducts resulting from exposure to ultraviolet [UV] radiation) is
recognizedbytheXPCandXPE(orUVDDB)proteincomplexes,whicharespecificcomponentsofthe
global genome nucleotideexcision repair (NER) system. Damage that actually blocks transcription
(e.g.,cyclobutanepyrimidinedimers [CPDs]resulting fromexposuretoUVradiation) isdetectedby
thetranscriptioncoupledNERsystem(TCNER)system,whichinvolvestheCSBandCSAproteins.The
DNAhelix isopenedbytheXPBandXPDhelicasesof therepairandtranscriptionfactor IIH (TFIIH),
allowing damage verification by the XPA protein. Singlestrand binding protein RPA prevents
reannealing, and dual incisions in the damaged strand are made by the ERCC1XPF and XPG
endonucleases,excisingthedamageaspartofapieceof25to30bases.Thesinglestrandgapisfilled








polymerase (RNAP) continues transcribing its product past a lesion, potentially leading to
transcriptionalmutagenesis in a nondividing cell (Saxowsky and Doetsch, 2006). A lesion
may alter the expression level of a gene, through altering the transcription rate, some
lesions could transiently arrest the elongation process,while othersmay arrest the RNAP
complex completely (Tornaletti, 2009). The arrested RNAP complex may not be stable,
resulting in release of the arrested polymerase and nascent RNA product, or if stable,






repair factors which remove the lesion ((Altieri et al., 2008) and Figures 3 and 4). TCR
operates on bulky lesions like UVinduced CPDs (Mellon et al., 1987) and helix distorting
DNAdamage like cisplatinDNA crosslinks (Zhenet al., 1993) andDNAadducts formedby
benzopyrenediolepoxide(Chenetal.,1992).OxidativelesionsandnonbulkyDNAadducts,
like abasic sites and their oxidative derivatives may be sufficient to initiate TCR in vivo,
however,thecurrentmodelpostulatethatonlylesionsthatblockRNAPIIwillbesubjectto
TCR (Tornaletti, 2009). The in vitro and in vivo TCR studies performed so far have shown
various levels of RNAPII bypass of 8oxoG and thymine glycol (Tg), suggesting that other
factors,suchasthesourceofRNAPII;thesequencecontextand/orthetranscriptionsystem










accomplish transcriptioncoupled repair. TFIIH localizes to the arrested elongation complex with
xerodermapigmentosumcomplementationgroupG(XPG)andXPA(whichispossiblybroughttothe
scenebyXPAbindingprotein2(XAB2));replicationproteinA(RPA)arrivessimultaneouslyorshortly
thereafter. d The chromatin remodelling factors highmobility group nucleosomebinding domain
containing protein1 (HMGN1) and p300 loosen the nucleosome structure behind the polymerase;
RNAPII reverses direction, backtracking from the obstacle and degrading the nascent RNA product
through itscryptic3–5exonucleaseactivity,which isactivatedbyTFIIS.TFIIHwithassociatedXPG,
XPAandRPAremainatthesiteoftheobstacle,possiblymaintainingthebubbleofdenaturedDNA,
butwithout theRNA–DNAhybrid.XPAandRPAbind thesinglestrandedDNA in thevicinityof the
obstruction,providinglesionverificationandstrandspecificitybeforethenextsteps.eOnceRNAPII
has backtracked, TFIIH extends the denatured region around the lesion to ~30 nucleotides, thus
settingupthesubstrateforthesubsequentDNAnickingbythestructurespecificendonucleasesXPG










Cockayne syndrome (CS) is a very rare autosomal recessive neurodegenerative disorder
characterized by severe postnatal growth failure, photosensitivity, microcephaly,
psychomotor delay, retinal degeneration, sensorineural deafness and lipoatrophy (Nance
andBerry,1992;Pasquieretal.,2006;Laugeletal.,2009).CSbelongs to the familyofNER
disorders, and CS cells are specifically defective in TCR.Mutations in CSA (also known as
ERCC8) or CSB (also known as ERCC6), identified in 1995 and 1992, respectively, are
responsibleformostcasesofCS(Troelstraetal.,1992;Troelstraetal.,1993;Henningetal.,
1995).Clustersofmissensemutations inCSAandCSB canberecognizedandhighlight the
role of particularmotifs in the proteins, however,many types ofmutations are scattered
along thewholecoding sequenceofbothgenes (Laugeletal., 2009).Rarecasesofmixed
XP/CSphenotypeshavebeen linked tospecificmutations in theXPB,XPDandXPG genes.
TheseXP/CSpatients showa specifically severe clinical photosensitivity, cancerproneness
andhaveacombineddefectintheTCRandGGRpathways,causingmutagenesisandcancer
in some tissuesandaccelerated cell deathandprematureaging inothers (Andressooand
Hoeijmakers,2005).Inpatients(Weidenheimetal.,2009),andmousemodels(Laposaetal.,
2007), the Purkinje cells of the cerebellum seem to be sensitive to degeneration and
containsmanymarkersofDNAdamage.IncontrasttoCSindividuals,CsaandCsbmutant





(WD) amino acid residues are usually found at the end of the motif and theWD repeat
proteinsarethoughttoformcircularizedbetapropellerstructuresinwhichtherepeatunits
mayserveasascaffoldforproteinproteininteractions(LiandRoberts,2001).CSAhasbeen
shown to interact with CSB, XAB2, and the p44 subunit of TFIIH (Henning et al.,
1995;Nakatsuetal.,2000).TheE3ubiquitin ligasecomplexcontainsCSA (Groismanetal.,
2003),andthiscomplexisrequiredfortherecruitmentofotherancillaryNERfactorstothe
repair site ((Fousteri et al., 2006) and Figure 4) and is probably able to trigger the
degradation of CSB at a late stage of the TCR process (Groisman et al., 2006). After UV
irradiation,andinthepresenceoffunctionalCSBandTFIIH,theCSAproteinistranslocated
tothenuclearmatrix(Saijoetal.,2007)andcolocalizeswiththehyperphosphorylatedform
ofRNAPIIstalledat the lesion.CSA isalso involved intheresponsetooxidativestressand
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AP sites and singlestrand breaks in DNA. Such lesions are introduced by reactive oxygen
species, methylation, deamination and hydroxylation (Lindahl, 1993;Seeberg et al.,
1995;Dalhus et al., 2009). The BER pathway is responsible for removal ofmore than ten
thousand DNA lesions daily in each human cell (Lindahl, 1993). Two subpathways exist,
shortpatch(SP)BERandlongpatch(LP)BER((Robertsonetal.,2009)andFigure5).TheSP
BER replaces a single nucleotide, whereas the LPBER subpathway results in the




depurination leading to base loss, aswell as iii) by SSBswith 3’ and 5’ ends that require
processingprior to ligation (Krwawiczetal., 2007). Todate,11differentmammalianDNA
glycosylases have been identified. Some are highly specific whereas other recognize
apparentlyunrelatedtypesofbaselesions(Dalhusetal.,2009;Robertsonetal.,2009).Some
DNA glycosylases possess an additional intrinsic AP lyase activity which cleaves the DNA
chain 3’ to the AP site forming a 5’ phosphate and a 3’fragmented deoxyribose. The
resultingcytotoxicandmutagenicAPsiteneedstobefurtherprocessed.APendonuclease1
(APE1)isthemajorAPendonucleaseinmammaliancells(Loeb,1985).APE1producesanick
in the backbone of the phosphodiester bond 5’ to the AP site, which creates a 5’
deoxyribose phosphate (dRP) group that is cleaved by DNA polymerase 	 (Allinson et al.,






The major polymerase in BER is POL	, which mainly insert singlenucleotides. However,
POL	isalsoabletoinsertthefirstnucleotideinLPBER(Podlutskyetal.,2001;Beardetal.,
2006). LPBER DNA synthesis is mainly carried out by DNA polymerase  (POL), a high
fidelity replicativeDNA polymerasewith intrinsic exonuclease (proofreading) activity, but
Introduction
22 
also POL has been implicated, together with POL	 (Stucki et al., 1998;Podlutsky et al.,
2001;Dianovetal., 2003;Asagoshiet al., 2010). The5’ singlestrandDNAdisplacedby the






BER pathways. OGG1, 8oxoguanineDNA glycosylase; NTHL1, nth endonuclease IIIlike 1; NEIL, nei
endonucleaseVIIIlike;MUTYH,mutyhomolog;MPG,NmethylpurineDNAglycosylase;UNG,uracil
DNA glycosylase; SMUG1, singlestrandselective monofunctional uracilDNA glycosylase; TDG,
thymineDNA glycosylase; MBD4, methylCpG binding domain protein 4; APEX1, APEX nuclease 1;
POL, DNA polymerase; FEN1, flap structurespecific endonuclease 1; LIG,DNA ligase; PCNA,
proliferatingcellnuclearantigen;RPA,replicationproteinA;RFC,replicationfactorC;WRN,Werner
syndromeprotein;EP300,E1Abindingprotein(aliasp300);BLM,bloomsyndromeprotein;CDKM1A,






Flap structure specific endonuclease 1 (FEN1) is best known for its involvement in RNA
primerremovalduringOkazaki fragmentprocessing in laggingstrandDNAreplication,and
for its 5’flap cleavage in LPBER (Figure 5) (Harrington and Lieber, 1994;Klungland and
Lindahl, 1997;Bambaraet al., 1997;Lieber, 1997;Liuet al., 2004). FEN1 is both a structure
specific5’flapendonucleaseanda5’3exonuclease,andithasalsobeenshowntopossess
agapendonucleaseactivity(HarringtonandLieber,1994;Muranteetal.,1994;Parrishetal.,
2003;Zheng et al., 2005). The preferred substrate for FEN1 is a double flap structure
containinga1nucleotide3’tailontheupstreamprimeradjacenttothe5’flap(Kaiseretal.,
1999;Storicietal.,2002;Kaoetal.,2002;FriedrichHeinekenetal.,2003;Fingeretal.,2009).
The multiple biochemical activities of FEN1 have been reviewed recently (Shen et al.,
2005;Zhengetal.,2011b).

In higher organisms, FEN1 has a Cterminal conserved domainmediating interactionwith
proliferatingcellnuclearantigen(PCNA),the“DNAslidingclamp”whichstimulatesFEN1by
enhancing FEN1’s binding stability and cleavage efficiency in vitro and in vivo (Li et al.,











in switching the orientation of FEN1 from an active into an inactive orientation. In an
















In the Cterminal of eukaryotic FEN1, the very last 26 amino acids represent the motif
responsible for nuclear localization of the protein. In mammals, FEN1 is the only known
nuclear flap endonuclease. A few years ago, LPBERwas discovered also inmitochondria
alongwith5’exo/endonucleaseactivity (Liuetal.,2008;Szczesnyetal.,2008;Akbarietal.,
2008). Until recently, mitochondria were thought to have only SPBER, and although the
studiesdisagreeon somedetails, theyall detect LPBER inmitochondria. Inmitochondrial
extracts fromHeLa andHaCaT cells, generation and removal of 5’ flaps as in LPBERwas
identified, whereas FEN1 was not (Akbari et al., 2008). On the contrary,  mitochondrial
extract fromhuman lymphoblastswas foundtocontainFEN1,and FEN1wasproposedto
have a role in mitochondrial LPBER (Liu et al., 2008). The third lab, which prepared
mitochondrialextractsfrommousetissueandhumancoloncancerHCT116cells,observed
anunidentifiedLPBER5’exo/endonucleaseactivity.TheactivitycouldnotbecreditedFEN1,
however, FEN1 was observed in the mitochondria and could cut 5’ flaps, e.g. generated
during DNA synthesis (Szczesny et al., 2008). The missing 5’ flap endonuclease was then
foundbyZhengand colleagues (Zhengetal., 2008),who show that thehelicase/nuclease
hDNA2  participates, together with FEN1, in human mitochondria LPBER. DNA2 was
originallyidentifiedinyeastasanuclearDNAhelicasewithendonucleaseactivity,processing
5’ flaps togetherwith FEN1 (Budd and Campbell, 1997). A few years ago, DNA2was also
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The important role of FEN1 (RAD27) in DNA metabolism is demonstrated by the severe
biologicaleffectsuponlossof it(Reaganetal.,1995;Kucherlapatietal.,2002;Larsenetal.,
2003). In yeast,RAD27 nullmutants are conditionally lethal at high temperatures,with a
defect in DNA replication.Mutants show sensitivity toUV radiation and alkylation agents
and also deficiencies in telomere maintenance (Reagan et al., 1995;Sommers et al.,
1995;ParenteauandWellinger,1999).Inmice,deletionofbothFen1allelesresultsinearly
embryonic lethality, with death at the blastocyst stage (Larsen et al., 2003).




based on these results in yeast, it was suggested that mammalian FEN1 was involved in
mechanisms through which trinucleotide repeat (TNR) expansions occur (Gordenin et al.,
1997;Spiro et al., 1999). In more than 30 human neurological, neurodegenerative and
neuromuscular diseases repeat expansion has been identified as a cause of the disease.
These includes Huntington disease (CAG/CTG), myotonic dystrophy type 1 (CTG/CAG),
Friedreichataxia(GAA/TTC),FragileXsyndrome(CGG/CCG),andmanyothers(Paulsonand
Fischbeck, 1996;Pearson et al., 2005;Lopez et al., 2010). CAG repeat instability is also
associatedwith human cancer (Andersson et al., 2006;Schildkraut et al., 2007). A linkage
between repeat expansion in brain andoxidativeDNAdamage has been established, in a
studywhereOGG1was found to initiateagedependentCAG repeatexpansion in somatic
cells (Kovtun et al., 2007). Recent studies show that FEN1 can promote CAG repeat
expansion, if the coordination of POL	 and FEN1 is disturbed during LPBER (Liu et al.,
2009;Goula et al., 2009). Tissue specific levels of these BER proteins may explain the
increasedCAG instability observed in striatum compared to the cerebellum inHuntington
disease(HD)mice(Goulaetal.,2009).

FEN1 has also been implicated in nonhomologous end joining (Wu et al., 1999),
microhomologymediated endjoining (MHEJ) (Liang et al., 2005), telomere stability







The cloning  of genes encoding fluorescent proteins, e.g. green fluorescent protein (GFP)
from jellyfishAequorea victoria (Shimomuraet al., 1962), and the engineered fluorescent
protein derivatives have allowed detailed studies of protein expression and mobility by
fluorescencemicroscopy(Chalfieetal.,1994;Tsien,1998).Currentadvancesinapplications
ofopticaltechniquestogetherwithexpressionoffluorescentproteinshaveallowedamazing
localization and quantification studies in live cells (Waters, 2007;Day and Schaufele,
2008;Wang et al., 2008). Fluorescence microscopy of GFPtagged proteins in intact living
cells allows the study of dynamic cellular processes under physiological conditions,which
representsanimmenseadvantagetofixedcells(Essersetal.,2006;Giepmansetal.,2006).A
wide range of genetically encoded fluorescent proteins are available for live cell imaging,
rangingfromdeepbluetodeepredofthevisiblespectrum((DayandSchaufele,2008)and
Figure7).Thus,severalproteinscanbevisualizedsimultaneouslyusingfluorescentproteins
from different parts of the spectrum, and proteinprotein interactions can bemonitored.
Moreover, some of the fluorescent proteins have unusual characteristics thatmake them
usefulreportersofthedynamicbehaviorofproteinsinsidecells(DayandSchaufele,2008).

Figure 7Multicolor labeling, living HeLa cells, Olympus FV1000 confocal microscope. TagBFPH2B











the fluorophore, and the molecule is photostable. In addition to the chromophore
mutations, EYFP contains >190 silent mutations that create an open reading frame
comprisedalmostentirelyofpreferredhumancodons(Haasetal.,1996;Yangetal.,1996).
Furthermore,upstreamsequencesflankingEYFPhavebeenconvertedtoaKozakconsensus
translation initiationsite (Kozak,1987).Thesechanges increase the translationalefficiency
of the EYFP mRNA and consequently increase the expression of EYFP inmammalian and
plant cells (Tsien, 1998). EYFP with Nterminal fusion moieties retains the fluorescent





for wholebody imaging and detection of cancer ((Gross and PiwnicaWorms, 2005) and
Figure8).Fluorescentproteinshavefacilitatedtheengineeringofhighlyspecificbiosensors
to visualize intracellular processes including protein kinase activity, apoptosis, membrane
voltage, cyclic nucleotide signaling, tracing neuronal pathways, pH and metal–ion
concentration(Lalondeetal.,2005;Lietal.,2006;Wangetal.,2008;Stepanenkoetal.,2008).
Recent achievements using fluorescent proteins include the Brainbow project, an elegant
experimentwhereindividualneuronsinthebrainaremappedwithfluorescentproteinsand






structural and functional studies, respectively, although boundaries between them are often quite
fuzzy.(Figureandlegendfrom(Chudakovetal.,2010)).
1.3.2 Fluorescencemicroscopy
Fluorescent microscopes use a specific wavelength of light to excite fluorochromes
(Lichtman and Conchello, 2005). In the biological field, antibodies are labelled with
fluorochromesandusedtotagcellularstructures.Emittedfluorescenceispassedthroughan
emissionfilterandcollectedusingacooledchargecoupleddevice(CCD)camera((Lichtman
andConchello,2005)andFigure9Left).Thicksampleswill causeoutoffocus light toblur
imagesmakingitdifficulttoresolvefinedetails.Confocalmicroscopyusesapinholetoblock
out of focus light and therefore increase optical resolution ((Furrer andGurny, 2010) and
Figure 9 Middle). The light source is usually a single wavelength laser allowing tight
illumination focus (Furrer andGurny, 2010). Samples can be optically sectioned (z stacks)
and the resulting images can thenbe reconstructed into a 3Ddata set (Brakenhoffet al.,
1985;Conchello and Lichtman, 2005).Multiphoton fluorescencemicroscopy allows optical
sectioning of thick samples using twophotons of light and leads to excitation only at the
focalpoint((Denketal.,1990;Hadjantonakisetal.,2003)andFigure9Right).Therefore,all
lightcollectedbythesystemmustbefromtheplaneoffocus.Becausetwophotonemission
must inherently occur at a discrete point, pinholes are not required (Nowotschin et al.,
2009). Using longer wavelengths (near infra red) provides several benefits including less
phototoxicityanddeeperpenetration,allowing imagingaround500microns intoasample
(Zipfel et al., 2003;Helmchen and Denk, 2005;Makale et al., 2009;Andresen et al.,





of threedimensional cultures like organotypic explants can elucidate essential cellular
functions like tissuespecific architecture,mechanical andbiochemical signals and cell–cell
communication,whichislostinmonolayer“petridish”cellcultures(Pampalonietal.,2007).
  
Figure 9 Fluorescence microscopy images. Left A widefield microscopy image showing a double
transgenicmouseembryo,18.5days(17x).Theimagewascapturedusingbrightfieldaswellasgreen
andredfluorescentfiltersindarkfield(GloriaKwon,MemorialSloanKetteringInsitituteNewYork).
Middle A confocal fluorescence microscope image of “Brainbow” transgenic mouse hippocampus




Fluorescence recovery after photobleaching (FRAP) is a method developed to detect
motions of substances in the cell (Axelrod et al., 1976). During FRAP a region is
photobleachedwith highpower laser irradiation followed by lowpower laser scanning to
observe and measure the speed of fluorescence recovery in the bleached region
(HoutsmullerandVermeulen,2001;Wangetal.,2008).Thecharacteristicsofredistribution






Figure10 Fluorescence recoveryafterphotobleaching.aAcell expressing fluorescentmolecules is
imagedwith low light levelsbeforeandafterphotobleaching the stripoutlined in red.Recoveryof





populations recovering at two different rates (simulated by a double exponential curve shown in
orangecircles).Notethatthekineticsforrecoveryofthelattertakesmuchlongertoplateau.cThe
leveloffluorescencerecoveryinthephotobleachedregionrevealsthemobileandimmobilefractions
of the fluorophore inthecell.dAsimpletest forphotoinduced immobile fractions is toperforma
secondFRAPexperimentinthesameregionof interest. Intheexamplehere,themobilefractionof








The projects presented herewere initiated to increase our knowledge of DNA repair and
investigate consequences of deficientDNAexcision repair in humanandmice. In the first
partofthework,weaimedtofindthediseasecausingmutationintwopatientswithclinical
featurestypicalofCockayneSyndrome(CS).Giventhatthenumberofstudieslinkingclinical





mouseFEN1.FEN1 isessential forDNAreplicationandLPBER.Previousstudies inour lab
revealedearlyembryoniclethalityofFen1knockoutmice.TwoFen1knockinmodelswere






this, we generated and characterized knockin mice expressing FEN1 fused to YFP, and


















(WD) repeat protein. Up to now, nine different CSA mutations have been identified.We
examinedtwoSomalisiblings9and12yearsoldwithclinicalfeaturestypicalofCSincluding
skin photosensitivity, progressive ataxia, spasticity, hearing loss, central and peripheral
demyelination and intracranial calcifications. Molecular analysis showed a novel splice
acceptor site mutation, a G to A transition in the 1 position of intervening sequence 6
(g.IVS61G>A),intheCSA(excisionrepaircrosscomplementing8(ERCC8))gene.IVS61G>A
results in anew28aminoacidCterminus andpremature terminationof theCSAprotein





Flap endonuclease 1 (FEN1) processesOkazaki fragments in lagging strandDNA synthesis,





amino acid substitutions in the highly conserved PCNA interaction domain of FEN1
(Fen1PCNA/PCNA). Fen1E160D/E160D mice develop a considerably elevated incidence of Bcell
lymphomasbeginningat6monthsofage,particularlyinfemales.By16monthsofage,more







patchbaseexcision repair (BER)and inDNA replication.Here,wehavegeneratedanovel
mousemodelwhichallowsformonitoringthekineticsofFEN1inresponsetoDNAdamage
in live cells. The expression of the enhanced yellow fluorescent protein (eYFP), is here
regulated by the endogenousFen1 promoter, and is fused to FEN1. The FEN1YFPmouse
enabledustocharacterizeexpressionlevelsanddistributionofFEN1YFPinculturedmouse
cellsand in live tissues.According to its role inprocessingofOkazaki fragments in lagging
strandDNA synthesis, FEN1expression ismost readily found inhighlyproliferating tissue,
however, FEN1 expression was also seen in the brain. Moreover, the FEN1YFP fusion
proteinallowedustoinvestigaterepairkineticsincellschallengedwithlocalandglobalDNA
damage and following poly (ADPribose) polymerase (PARP) inhibition. In vivo 2photon
fluorescencemicroscopydemonstratesrapidrelocationofFEN1atlocalDNAdamagesitesin
thelaserirradiatednuclei,providingevidenceofahighlymobileproteinwhichaccumulates











et al., 2007). Deficiencies in BER and NER can range from a complete lack of essential
protein(s)tosubtlemutationsandSNPswhichcanresultinabroadspectrumofphenotypes,
as illustrated in papers I and II, and studies referred to throughout the introduction and
discussion of this thesis. Premature aging, cancer, neurodegeneration and developmental
disorders are the main diseases resulting from deficient excision repair (Xu et al.,
2008;Niedernhofer,2008;Cleaveretal.,2009).

Aging is a complex phenomenon, characterized by increased susceptibility to cellular loss
andfunctionaldecline,wheremitochondrialDNAmutationsandmitochondrialDNAdamage
responsearethoughttoplayimportantroles.MitochondriaarethemajorsourceofROSin
thecell,andareshowntoutilizemitochondrialBER (mtBER) inorder to removeoxidative
damage and avoid mutations in the mitochondrial DNA (Larsen et al., 2005;Gredilla,
2010;Boesch et al., 2011). Emanating ROS from the electron transport chain can cause
mtDNA damage and mutations which might result in dysfunctional mitochondrial
respiration, further rising ROS generation and oxidative damage. This socalled “vicious
cycle” of ROS generation and oxidative damage is one hypothesis for aging associated





or posttranslationally modified versions of the nuclearencoded proteins. NER is not
thoughttobeactiveinmitochondria,atleastnotintheclassicalnuclearform,andclassical
NER substrates like thymidinedimers, cisplation intrastrand crosslinks and complex alkyl











death and senescence leading to accelerated aging while protecting against cancer
(Hoeijmakers, 2009). Reducing ROS and the damage load through avoidance or limited
exposure to exogenous genotoxins and suppressed metabolism can delay cancer
development or the agingprocess (Blagosklonnyet al., 2010). Both caloric restriction and
DNAdamagecanelicitaprotectivesurvival responsethatpromotes longevityandhealthy
aging (Garinis et al., 2008;Schumacher et al., 2009). This survival response includes
suppression of growth hormone (GH)/insulin growth factor (IGF)1 somatotroph axis and
suppressionofoxidativemetabolism(Niedernhoferetal.,2006;van,Ietal.,2007).Theshift
from growth and proliferation to preservation of somatic maintenance also involves






glycosylases, OGG1 and MUTY, result in high incidence of lymphomas, lung tumors and





Given the severe cancerprone phenotype of XP patients one could question whether
variation in NER capacity in the general population is associatedwithmore subtle risk of
sporadiccancer.OnestudyidentifiedanassociationofSNPsintheXPCgenewithincreased
lungcancerrisk inaChinesepopulation(Baietal.,2007).CommonvariationofotherNER
associated proteins, like the MMS19L protein which interacts with XPD, is linked with
increased risk of pancreatic cancer (McWilliams et al., 2009). Further research, in large
Discussion
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more indetail inpaper I.AlthoughsomeoverlappingsymptomsexistbetweenXP,CSand
TTD,pathogenesisdiffersamongandwithin thesyndromes,with theprimarydefect inXP
being lossofneurons,whereasabnormalmyelin is themajorneuropathological feature in
TTDandCS(Brooksetal.,2008).ItisspeculatedthattheclassicDNAdamageaccumulation






either destabilize TFIIH or affect the transcription function result in TTD or the XPCS
complex. TFIIH open DNA during NER and transcription, however, it also functions as a
kinase that phosphorylates nuclear hormone receptors (RochetteEgly et al.,
1997;Chymkowitchetal.,2011).Moreover,TFIIHcanfunctionasacoactivatorforthyroid
hormonedependent gene regulation, and the neurologic disease in human TTD patients
might be explained by dysregulation of thyroid dependent gene expression in the brain,
resulting in aberrantmyelin gene expression (Compeet al., 2007). “Pure” CS cells display
normal nuclear hormonedependent transcription, whereas reduced phosphorylation of
nuclear hormone receptors levels explains the hormonedependent transcription defect
observed in XPGCS cells (Ito et al., 2007). Despite the phenotypic similarity between CS,




TTD and CS, and also in another rare genetic disease, AicardiGoutières syndrome (AGS)
(Brooks et al., 2008). Myelin, the “white matter”, lipidrich insulating material forming a
layer around the axons of neurons, is synthesized by specific types of glial cells called
oligodendrocytes(Brooksetal.,2008).AGScanbecausedbymutations ineitherTREX1or
RNASEH2, and is characterized by failure to degrade endogenous DNA in the absence of
Discussion
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these nucleases, where upon undegraded endogenous nucleic acids activate an innate
immuneresponse,resultinginincreasedproinflammatorycytokineIFNproduction(Brooks
et al., 2008;van Heteren et al., 2008;Stephenson, 2008). Secretion of IFN in the
extracellularspaceofthebrain,andthereforeintothecerebrospinalfluid(CSF),canacton
otherbraincelltypes,includingvasculatureandoligodendrocytes,resultingininflammation,
dysmyelination and brain calcification (Lebon et al., 2002;Brooks et al., 2008). Vascular
degeneration,particularlyseeninmicrovessels, ispresent inCS(Weidenheimetal.,2009),
moreover, gene expression changes (Newman et al., 2006) and evidence of inflammation
has been observed in CScells (Weidenheim et al., 2009). The defective TCNER may
contributetothe“viciouscycle”ofneuroinflammationandcelldeathinCSbrain.Overlapin
neurological symptomsbetweenCS andAGS suggests that vascular changes, andperhaps
alterations in gene expressionmay play a role in thewhitematter phenotypes and brain




more oxygen than other organs and is vulnerable to ROSinduced damage (Intano et al.,
2001;Karahaliletal.,2002;Hegdeetal.,2011).AgeassociateddeclineofBERactivityinthe
centralnervoussystemhasbeenlinkedtoneurodegenerativedisorders,implyingarolefor
impaired BER in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD),




oxidativedamage inADpatients could indirectly impairDNA repairproteins, e.g.bypost
translational oxidative inducedmodificationsordegradationofOGG1activity (Shaoetal.,
2008;Hill et al., 2008). On the other hand, increased OGG1 levels were observed in the















and further discusses possible genotypephenotype correlations and motiffunction




of them are contained in WD motif 4. The WD motifs are required for proteinprotein
interactionsandtobuildthebetapropellerstructure.Interestingly,thestructureofanother
WD40repeat protein, DDB2 in the UVDDB complex, revealed that the DDB2 WD40
propellerexclusivelybinds the lesion, illustratedbyeither64PP lesionoranabasicsite in
the DNA duplex bound to the DDB1DDB2 complex (Scrima et al., 2008). DDB1DDB2
associatestightlywiththeCUL4ARBX1ubiquitinligasecomplex(Scrimaetal.,2008).DDB2
is one of many specific substraterecognizing DDB1CUL4 associated factors (DCAFs), and
CSA is one of the DCAFs taking the place of DDB2 in a similar ubiquitin ligase complex
(Sugasawa, 2009;Abbas andDutta, 2011). Thep.Ala205Promutation located in the fourth
WDmotifhasbeenshowntoabolishbindingofCSAtooneofitsinteractors,DDB1(Caoet






skin abnormalities, with normal growth and neurological development, and without any
increased risk of cancer. Despite themild symptoms,UVSS cells display the same TCNER
defectasCScells(Nardoetal.,2009).UVSScanbecausedbytheCSAmutationmentioned
above, but also by the complete lack of CSB protein, or by a complementation group
unknowntodate (Fujiwaraetal.,1981;Itohetal.,1994;Horibataetal.,2004;Nardoetal.,




in this field (Weidenheim et al., 2009). Human CSA and CSB mutations have largely
overlappingphenotypesandaregenerallyclinicallyindistinguishable(Stefaninietal.,1996).
Todate,mutatedCSAhasnotbeendescribedinthemostseveretypeIICSorintheprenatal
cerebrooculofacioskeletal (COFS) syndrome.MutatedCSB is identified in all types of CS
andtheverysevereCOFS,also,cataractsareoftendescribedinpatientswithmutatedCSB




thanhumanCSpatients. Yet, as for humans, thephenotypes ofCsa andCsbmutants are
impossibletoseparate(vanderHorstetal.,1997;vanderHorstetal.,2002).

CSAubiquitylates CSB for degradation. Thus, it seems contradictory that both lack of CSA
and lackofCSBcauseCS (Groismanetal.,2006). IfCSB ismutated, there isno functional
CSB,while noCSBdegradation via theubiquitinproteasomepathwayoccurswhenCSA is
mutated. Recently, CSA ubiquitylation and CSB function have potentially been connected
throughtheubiquitinbindingdomain(UBD)ofCSB(Anindyaetal.,2010;GrayandWeiner,
2010). Anindya and coworkers show that TCNER proteins assemble at the site of DNA


















oxoG, 8oxoA, and 5hydroxy2’deoxycytidine in bothCSA andCSBmutant genomic DNA
(Tuoetal., 2001;D'Erricoetal., 2007;Ropoloetal., 2007;Pascuccietal., 2011).Moreover,
impairedhostcell reactivationofplasmidscontaininga single8oxoGwasobserved inCS
deficientcells(SpivakandHanawalt,2006).SV40transformedCSAandCSBmutantcellsdid
not confirm the hypersensitivity to oxidative DNA damaging agents seen in CS deficient
primarycells (D'Erricoetal., 2007).Thus,one shouldbecautious inextrapolatingdataon
oxidativestresssensitivityintransformedcells,wheredifferentcellresponsesaredefective
compared to normal cells. A possible role of the CS proteins in protection fromoxidative
damagewasrecentlyshownbyfunctionalincreaseofCSAandCSBinsidemitochondria(mt),
andcomplexformationwithmtDNA,mtOGG1,andmtsinglestrandedDNAbindingprotein
(mtSSBP)1 upon oxidative stress in human cells, linking BER and NER (Kamenisch et al.,
2010). Impaired repair of oxidative lesions throughout the genome is suggested to
contribute to the CS phenotype, as reduced GGRwas observed in CSA and CSB deficient
humancells(Cramersetal.,2011).TCR,ontheotherhand,isnotinvolvedintheprocessing
of ionizing radiation inducedoxidative lesions, anddefectiveTCR is thushighlyunlikely to
underlietheradiationsensitivityofCS(Cramersetal.,2011).TheinvolvementofGGR,TCR
andchromatinremodelingproteins inUVinducedrepairhasbeenproposedtodependon





FEN1 is absolutely required for removal of RNA/DNA primers during Okazaki fragment




FEN1 YFPHis6HA (entitled FEN1YFP) fusionprotein. Thenucleasemutant is characterized
with high incidence of lymphoma, whereas a mutation of the PCNAinteraction domain
causes early embryonic lethality. In linewith our results, Zheng and colleagues show that
F343AF344AmutationsinthePIPdomainofFEN1inmicedisruptsFEN1’sabilitytointeract
withPCNA(Zhengetal.,2007a;Zhengetal.,2011a).TheheterozygousF343AF344Amutant
miceencompassbothdefectRNAprimer removalandLPBER, resulting innumerousDNA




et al., 2011a). FEN1 is thought to be both a tumor suppressor protein and an enzyme
upregulatedinhyperproliferatingcancercells.InaccordancewithincreasedFEN1expression
incancercells,decreasedCpG2methylationoftheFEN1promoterisassociatedwithbreast
cancer (Singhet al., 2008;Lahtz andPfeifer, 2011). Thus FEN1 canpromote cancer in two
different ways; mutated FEN1 can increase genomic instability and initiate malignant
transformation,whileFEN1overexpressiongivesthetumorsagrowthadvantage(Zhenget
al., 2011b). Furthermore, themutantmousemodels suggest twodifferent cancer causing
mechanisms as presented by Zheng and Shen (Zheng and Shen, 2011). One mechanism
whichcouldleadtocancerisillustratedbytheF343AF344Amutant,withaneuploidcancer






(Zhengetal., 2011a). F343AF344Amutant FEN1may removenucleotides from the5’ end
nickedDNAends,causingunwantedcyclesofgapfilling,DNAcleavageandligation(Zhenget
al.,2011a).Thedefects inRNAprimer removalandLPBERresult in frequentDNAbreaks,
activationofG2/McheckpointproteinChk1, and induceaneuploidy (Zhengetal., 2011a).




DNA polymerase , removed by FEN1 if displaced into the 5’ flap, or removed by 5’
exonuclease activity of FEN1 if not displaced in the flap. Incorporation errors can also be
removedbythemismatchrepairpathway(ZhengandShen,2011).Thesolecontributionof
BERdeficiencytoformationofspontaneouscancerinFEN1E160Dmiceisdifficulttoassess,
due to other DNAmetabolic defects in thesemice, including apoptotic DNA degradation








Xu et al. demonstrate that the E160D FEN1 mutant is deficient in processing LPBER





Recent biochemical and genetic studies provide evidence that posttranslational
modificationsoftheFEN1proteinareinvolvedinregulationofproteinproteininteractions
and also determine the cellular localizations of FEN1 (Zheng et al., 2011b). Acetylation
(Hasan et al., 2001), phosphorylation (Henneke et al., 2003) andmethylation (Guo et al.,
2010)arethreemodificationsfoundtoregulateFEN1invivo,wheremethylationofresidue
R192 in FEN1preventsphosphorylationat its residueS187 (Guoetal., 2010).Methylated
FEN1interactswithPCNA,whereasphosphorylatedFEN1dissociatesfromPCNA(Guoetal.,
2010).ThisprovidesnovelinsightintothemechanismfortheFEN1nucleasetodynamically
associatewith and dissociate from PCNA and the DNA substrate. It has been proposed a
model of sequential actions where methylated FEN1 replaces the DNA polymerase and
access PCNA and the flap structure, upon flap cleavage FEN1 is demethylated by an





the cell use acetylation of BER and replication proteins to allow controlled removal of a
greater number of nucleotides with high accuracy (Hasan et al., 2002;Bhakat et al.,
2003;Bhakatetal.,2006;Balakrishnanetal.,2010).OurkineticstudyontheFEN1YFPfusion
protein to sitesofDNAdamage in live cells (paper III), revealeda fast accumulatingFEN1
with high turnover, in line with the dynamical regulation of FEN1 by posttranslational
modifications.

IfaBERcomplexexists remain tobeelucidated,however, JaiswalandNarayanargue ina
recent study that a complex with all the essential BERcomponents, including FEN1,




and did not change with the time course of the assembly of the complex (Jaiswal and
Narayan,2011).FurtherinsupportofFEN1inaBERmultiproteincomplex,HanssenBaueret
al.suggestthatXRCC1organizesBERintomultiproteincomplexesofvaryingsize,depending
on thenature and context of theDNAdamage (HanssenBaueret al., 2011).  Amodel of
threemodesofBER ispresented,FEN1 is thought totakepart intheBERcomplexathigh
levels of DNA damage and in replicationassociated BER, but not in the classic BER at
endogenousandlowlevelsofinducedDNAdamage(HanssenBaueretal.,2011).Ithasalso
been proposed that LPBER function by sequential enzyme actions in the context of a
multienzyme complex that remains structurally intact during the repair process
(Balakrishnan et al., 2009). Yet, another suggestion is that preformed BER complexes




To examine the mobility and kinetics of FEN1 in vivo we generated a knockin mouse
expressingEYFPtaggedFEN1fromtheendogenousFen1 locus(PaperIII).Whenevaluating
the results, we have to take into account thatwe observe a tagged FEN1 protein, which
possiblycouldbedisturbedascomparedtoitswildtypestate.Theaimwhengeneratinga





EYFP gives a bright fluorescent signal, and it can be used in conjunction with far red
fluorescent labeling, enabling simultaneous imaging of two fluorescent proteins, possibly
colocalizing,withoutfalsepositivesignalorbleedthroughfluorescence.ThesizeofEYFP,27
kDa,witha	–barrel3nm indiameterand4nm long, representsasignificantadditiontoa
protein and thusmay have steric consequences for protein folding, function, or targeting
(Yang et al., 1996). Therefore, one needs to be cautious when evaluating results of the
fusion protein when it comes to localization, proteinactivity and proteinprotein
interactions,andcompareto,ifknown,thesecharacteristicsofthenativeuntaggedprotein.





lengthand life span (Hastyetal., 2003;MestasandHughes,2004;Demetrius,2005).While




not appear to lead to demyelination and other severe neurological decline in mice, in
contrast to the detrimental neurological abnormalities seen in human. Although no good
model of the main CS phenotype exists, the single knockout mouse model seems to
correspond to mild UVSS, while TCR/GGR double knockout mouse models, deficient for
either Csb and Xpa or for Csb and Xpc, seem to correspond to the severe COFS
(Niedernhofer,2008;Cleaveretal.,2009).Furtheranalysisisneededtofindoutwhetherthe
primarydefectisneurodegeneration(XP)ordemyelination(CS).Asmousemodelsbecome
more refined, current limitations could be overcome by for example using combinatorial
gene inactivation approaches to mimic the neuropathology seen in human diseases. The
generalobservationofmilderphenotypes,especially lessneuropathology,ofNERdeficient





could well be due to the short lifespan of mice, and by the high UV doses assessed.
Conversely, unprotected XPpatients develop skin cancer at an early age (Cleaver et al.,
2009). While NER knockouts provide several mouse models of human disease, the BER
knockoutsaremostlyembryonic lethal,withtheexceptionofmice lacking individualDNA




in rodents (Xu et al., 2008). Mice deficient in BERfunction display severe phenotypes,










molecularandclinical levelwillpossibly revealdistinctbiological rolesof theCSAandCSB
proteins.However,themissingcorrelationseenbetweenmutationanddiseaseoutcometo
date necessitates investigations at the protein level, to clarify the functional and
coordinating roles of CSA and CSB alone and in the TCRcomplex. Fluorescently tagged
proteinsinlivecellscouldbeanimportanttoolinthestudyofmutatedCSproteinsandtheir








FEN1expression levels in different tissues and during development, from early twocell
stageviablastocystandembryogenesis,untildifferentiatedandeventuallypostmitoticcells
could be done in vivo, and the expression compared among tissuetypes, developmental
stagesandotherrepairproteins.CrossingFEN1YFPmicewithotherfluorescentlytaggedLP
BER proteins could be used for in vivo studies of proteinprotein interactions and
colocalizationatDNAdamagesites.To investigate further theroleofFEN1 inproliferative
cells, partial hepaectomy could be performed, and FEN1YFP expressionmonitored in the
rapid regenerating liver tissue. Also, tumor cells or tissues expected to have upregulated
FEN1inthehyperproliferatingcells,wouldbeinterestingtoevaluateandvisualize.FEN1YFP
isnotbyitselfexpectedtoincreasetheriskofcancerdevelopment,soeitherspontaneous
or chemically/radiation induced tumor would be prerequisite. Another option is to study
heterogenousmice,bycrossingFEN1YFPeitherwithaheterogenousBERdeficientmouse
or a cancermousemodel.Moreover, the kinetic studies of FEN1 initiated in our paper III
couldbeexpanded,includingmeasurementstoobtainKonandKoffdata,increasenumberof
cellsmonitored for longtime fluorescence recovery, treat cells withmore DNAdamaging
agentsanddoFRAP,compareFRAPonLDforFEN1indifferenttissues,e.g.brainandskin,
bothincellculturesandintissueslices.Bycombinedeffortofcomputationalmodelingand
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